<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".15" citation="COMAR 10.14.05.15" title_num="10" subtitle_num="14" chapter_num="05" heading="Grant Application Review and Approval and Grant Extensions.">
  <paragraph num="A.">
    <text>Each fiscal year the CCPC shall determine:</text>
    <paragraph num="(1)">
      <text>The amount of money available for grants under the Maryland Cancer Fund;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>The allocation of funding for cancer:</text>
      <paragraph num="(i)">
        <text>Research;</text>
      </paragraph>
      <paragraph num="(ii)">
        <text>Primary prevention;</text>
      </paragraph>
      <paragraph num="(iii)">
        <text>Secondary prevention; and</text>
      </paragraph>
      <paragraph num="(iv)">
        <text>Treatment; and</text>
      </paragraph>
    </paragraph>
    <paragraph num="(3)">
      <text>The maximum grant award amount for each type of grant.</text>
    </paragraph>
  </paragraph>
  <paragraph num="B.">
    <text>Each year the Department shall consider for award, funding for one or more of the following types of grant applications for cancer:</text>
    <paragraph num="(1)">
      <text>Research;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Primary prevention;</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Secondary prevention; and</text>
    </paragraph>
    <paragraph num="(4)">
      <text>Treatment.</text>
    </paragraph>
  </paragraph>
  <paragraph num="C.">
    <text>The CCPC shall develop one or more evaluation committees or shall contract with one or more external consultants with expertise in cancer research and prevention to review the cancer research and primary prevention and secondary prevention grant applications that are submitted for funding under the Maryland Cancer Fund.</text>
  </paragraph>
  <paragraph num="D.">
    <text>Due to the need for timeliness in the cancer treatment grants, the CCPC shall review each application for cancer treatment.</text>
  </paragraph>
  <paragraph num="E.">
    <text>The evaluation committee or external consultants shall review:</text>
    <paragraph num="(1)">
      <text>Cancer research grant applications based on:</text>
      <paragraph num="(a)">
        <text>Scientific need;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>The degree to which the cancer research plan will achieve the goals and objectives set forth in the plan;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>The inclusion of a plan for Institutional Review Board approval;</text>
      </paragraph>
      <paragraph num="(d)">
        <text>The feasibility of the timeline in delivering goals and objectives of the plan;</text>
      </paragraph>
      <paragraph num="(e)">
        <text>The experience and expertise of the principal investigator;</text>
      </paragraph>
      <paragraph num="(f)">
        <text>The degree to which a grant application addresses eliminating disparities between racial and ethnic minorities and the white population;</text>
      </paragraph>
      <paragraph num="(g)">
        <text>Whether the research is recommended in the Maryland Comprehensive Cancer Plan;</text>
      </paragraph>
      <paragraph num="(h)">
        <text>The lack of other resources or funding for the proposed research; and</text>
      </paragraph>
      <paragraph num="(i)">
        <text>The amount of the funding requested;</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>Cancer primary prevention grant applications based on:</text>
      <paragraph num="(a)">
        <text>The need for the cancer primary prevention activity;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>The previously documented effectiveness of the primary prevention intervention;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>The degree to which the cancer primary prevention plan will achieve the goals and objectives set forth in the plan;</text>
      </paragraph>
      <paragraph num="(d)">
        <text>The degree to which a grant application addresses eliminating disparities between racial and ethnic minorities and the white population;</text>
      </paragraph>
      <paragraph num="(e)">
        <text>The experience of the applicant in cancer primary prevention;</text>
      </paragraph>
      <paragraph num="(f)">
        <text>Whether the primary prevention intervention is recommended in the Maryland Comprehensive Cancer Control Plan;</text>
      </paragraph>
      <paragraph num="(g)">
        <text>The lack of other resources or funding for the proposal; and</text>
      </paragraph>
      <paragraph num="(h)">
        <text>The amount of funding requested; and</text>
      </paragraph>
    </paragraph>
    <paragraph num="(3)">
      <text>Cancer secondary prevention grant applications based on:</text>
      <paragraph num="(a)">
        <text>The previously documented effectiveness of the secondary prevention intervention;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>The need for the cancer secondary prevention intervention in the population group to be served;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>The degree to which the cancer secondary prevention plan will achieve the goals and objectives of the plan;</text>
      </paragraph>
      <paragraph num="(d)">
        <text>The feasibility of the timeline in delivering the goals and objectives of the plan;</text>
      </paragraph>
      <paragraph num="(e)">
        <text>The extent to which medical guidelines for screening and diagnosis are being followed;</text>
      </paragraph>
      <paragraph num="(f)">
        <text>The percent of the budget allocated to clinical services;</text>
      </paragraph>
      <paragraph num="(g)">
        <text>The degree to which the grant application addresses eliminating disparities between racial and ethnic minorities and the white population;</text>
      </paragraph>
      <paragraph num="(h)">
        <text>The experience of the applicant in cancer secondary prevention;</text>
      </paragraph>
      <paragraph num="(i)">
        <text>Whether the secondary prevention intervention is recommended in the Maryland Comprehensive Cancer Control Plan;</text>
      </paragraph>
      <paragraph num="(j)">
        <text>The lack of other resources or funding for the proposal; and</text>
      </paragraph>
      <paragraph num="(k)">
        <text>The amount requested.</text>
      </paragraph>
    </paragraph>
  </paragraph>
  <paragraph num="F.">
    <text>After reviewing each cancer research, primary prevention, and secondary prevention grant application, the evaluation committee or external consultant shall make a recommendation to the CCPC about whether to award grant funds to each applicant.</text>
  </paragraph>
  <paragraph num="G.">
    <text>The CCPC shall review each cancer treatment application based on:</text>
    <paragraph num="(1)">
      <text>Completeness;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Availability of funds; and</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Whether the application meets the relevant application process requirements set forth in this chapter.</text>
    </paragraph>
  </paragraph>
  <paragraph num="H.">
    <text>The Director of the CCPC shall recommend an application to the Secretary for approval based upon:</text>
    <paragraph num="(1)">
      <text>The evaluation committee's or external consultant's recommendations for awarding the cancer research, primary prevention, secondary prevention, and treatment grants for each application; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>The availability of funds.</text>
    </paragraph>
  </paragraph>
  <paragraph num="I.">
    <text>The Secretary shall:</text>
    <paragraph num="(1)">
      <text>Consider the grant recommendations of the CCPC for the cancer:</text>
      <paragraph num="(a)">
        <text>Research;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Primary prevention;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Secondary prevention; and</text>
      </paragraph>
      <paragraph num="(d)">
        <text>Treatment; and</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>Make the final determination on which grant applications to approve.</text>
    </paragraph>
  </paragraph>
  <paragraph num="J.">
    <text>A grant period expires 1 year from the date of award of the grant, unless extended as set forth in Regulation .16 of this chapter.</text>
  </paragraph>
  <paragraph num="K.">
    <text>A person awarded a grant under this chapter may apply for a no-cost extension of the grant period for the award before the expiration of the grant period, as set forth in §J of this regulation, by submitting a written request for an extension to the CCPC.</text>
  </paragraph>
  <paragraph num="L.">
    <text>In evaluating whether to grant an extension of the grant period, the CCPC:</text>
    <paragraph num="(1)">
      <text>Shall assess whether progress has been made on the grant; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>If progress has been made based on the reports submitted pursuant to Regulation .16C of this chapter, may recommend to the Secretary that an extension be granted.</text>
    </paragraph>
  </paragraph>
  <paragraph num="M.">
    <text>The Secretary may approve an extension for up to 1 year based on:</text>
    <paragraph num="(1)">
      <text>The recommendation of the CCPC; and</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Whether progress has been shown on the grant pursuant to Regulation .16C of this chapter.</text>
    </paragraph>
  </paragraph>
</regulation>